Copyright Reports & Markets. All rights reserved.

In vivo CRO Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

Buy now

1. Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2. Executive Summary

  • 2.1 Report Guide
  • 2.2 Methodology
  • 2.3 Market Segmentation
  • 2.4 In vivo CRO Market- Key Findings, 2020

3. Strategic Imperatives on Global In vivo CRO Market

  • 3.1 COVID-19 Impact Analysis
  • 3.2 Market Trends- Across Types, Applications, End User Types, Countries
  • 3.3 Insights into Main Market Categories
  • 3.4 Market Drivers and Restraints
  • 3.5 Growth Opportunities Critical for Future Success
  • 3.6 Key In vivo CRO Companies

4. Global In vivo CRO Market Value Outlook to 2026 Outlook by Services

  • 4.1 Rodent Based In Vivo GLP Type
    • 4.1.1 Rats Based In Vivo CRO
    • 4.1.2 Mice Based In Vivo CRO
    • 4.1.3 Others
  • 4.2 Non-Rodent Based In Vivo GLP Type
    • 4.2.1 Hamsters Based In Vivo CRO
    • 4.2.2 Guinea Pigs Based In Vivo CRO
    • 4.2.3 Gerbils Based In Vivo CRO
    • 4.2.4 Others Based In Vivo CRO

5. Global In vivo CRO Market Value Outlook to 2026 Outlook by Type

  • 5.1 Non GLP
    • 5.1.1 In House
    • 5.1.2 Outsourcing
  • 5.2 GLP Toxicology
    • 5.2.1 In House
    • 5.2.2 Outsourcing

6. Global In vivo CRO Market Value Outlook to 2026 Outlook by Indication

  • 6.1 Autoimmune/ Inflammatory Conditions
    • 6.1.1 Rheumatoid Arthritis
    • 6.1.2 Multiple Sclerosis
    • 6.1.3 Osteoarthritis
    • 6.1.4 Irritable Bowel Syndrome
    • 6.1.5 Others
  • 6.2 Pain Management
    • 6.2.1 Chronic Pain
    • 6.2.2 Acute Pain
  • 6.3 Oncology
    • 6.3.1 Blood Cancer
    • 6.3.2 Solid Tumor
      • 6.3.2.1 Syngeneic Model
      • 6.3.2.2 Patient Derived Xenograft
      • 6.3.2.3 Xenograft
    • 6.3.3 Others
  • 6.4 CNS Conditions
    • 6.4.1 Epilepsy
    • 6.4.2 Parkinson’s Disease
    • 6.4.3 Huntington’s Disease
    • 6.4.4 Stroke
    • 6.4.5 Traumatic Brain Injury
    • 6.4.6 ALS
    • 6.4.7 Muscle Regeneration
    • 6.4.8 Others
  • 6.5 Diabetes
  • 6.6 Obesity
  • 6.7 Others

7 Asia Pacific In vivo CRO Market Value Outlook to 2026

  • 7.1 Leading In vivo CRO Types contributing to Asia Pacific market
  • 7.2 Top Applications contributing to Asia Pacific In vivo CRO
  • 7.3 Top countries contributing to Asia Pacific In vivo CRO

8 Europe In vivo CRO Market Value Outlook to 2026

  • 8.1 Leading In vivo CRO Types contributing to Europe market
  • 8.2 Top Applications contributing to Europe In vivo CRO
  • 8.3 Top countries contributing to Europe In vivo CRO

9 North America In vivo CRO Market Value Outlook to 2026

  • 9.1 Leading In vivo CRO Types contributing to North America market
  • 9.2 Top Applications contributing to North America In vivo CRO
  • 9.3 Top countries contributing to North America In vivo CRO

10 South and Central America In vivo CRO Market Value Outlook to 2026

  • 10.1 Leading In vivo CRO Types contributing to South and Central America market
  • 10.2 Top Applications contributing to South and Central America In vivo CRO
  • 10.3 Top countries contributing to South and Central America In vivo CRO

11 Middle East Africa In vivo CRO Market Value Outlook to 2026

  • 11.1 Leading In vivo CRO Types contributing to Middle East Africa market
  • 11.2 Top Applications contributing to Middle East Africa In vivo CRO
  • 11.3 Top countries contributing to Middle East Africa In vivo CRO

12 Business Profiles of Leading Companies

  • 12.1 Business Description, SWOT and Financial Analysis of Companies in In vivo CRO market
  • 12.2 American Preclinical Services
  • 12.3 Charles River Laboratories
  • 12.4 Covance Inc.
  • 12.5 Evotec (US) Inc.
  • 12.6 Icon PLC
  • 12.7 Inventiv Health
  • 12.8 Parexel International
  • 12.9 Pharmaceutical Product Development
  • 12.10 Quintiles
  • 12.11 Theorem Clinical Research

13 Recent Industry Developments

    14 Appendix

    • 14.1 OGAnalysis Expertise
    • 14.2 Sources and Methodology

    The study predicts the short term and long term trends that can shape up the future of the In vivo CRO market including the COVID-19 pandemic implications for In vivo CROs industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.

    The In vivo CRO market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. In vivo CRO Companies are focusing on improving efficiency and containing costs in current COVID-19 market conditions. In vivo CRO market forecast and In vivo CRO market growth is outlook through 2026.

    The report reflects on predictions with 2019 as the base year and 2020- 2026 as the forecast period. The research was based on the findings of expert team of analysts analyzing the In vivo CRO market opportunities, underlying market factors, demographic and economic factors, market developments and others.

    In vivo CRO industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening In vivo CRO market share in developed countries.

    Scope of the research-

    Global In vivo CRO Market is analyzed and forecast over the outlook period from 2020 to 2026 By Services
    Rodent Based In Vivo GLP Type
    Rats Based In Vivo CRO
    Mice Based In Vivo CRO
    Others
    Non-Rodent Based In Vivo GLP Type
    Hamsters Based In Vivo CRO
    Guinea Pigs Based In Vivo CRO
    Gerbils Based In Vivo CRO
    Others Based In Vivo CRO

    Global In vivo CRO Market is analyzed and forecast over the outlook period from 2020 to 2026 By type including
    Non GLP
    In House
    Outsourcing
    GLP Toxicology
    In House
    Outsourcing

    Global In vivo CRO Market is analyzed and forecast over the outlook period from 2020 to 2026 By Indication
    Autoimmune/ Inflammatory Conditions
    Rheumatoid Arthritis
    Multiple Sclerosis
    Osteoarthritis
    Irritable Bowel Syndrome
    Others
    Pain Management
    Chronic Pain
    Acute Pain
    Oncology
    Blood Cancer
    Solid Tumor
    Syngeneic Model
    Patient Derived Xenograft
    Xenograft
    Others
    CNS Conditions
    Epilepsy
    Parkinson’s Disease
    Huntington’s Disease
    Stroke
    Traumatic Brain Injury
    ALS
    Muscle Regeneration
    Others
    Diabetes
    Obesity
    Others

    Top Companies Operating in In vivo CRO market include- American Preclinical Services , Charles River Laboratories , Covance Inc. , Evotec (US) Inc. , Icon PLC , Inventiv Health , Parexel International , Pharmaceutical Product Development , 120 Quintiles , 121 Theorem Clinical Research

    Buy now